SRPT
Sarepta Therapeutics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -7.1% ·
share flow +7.4% ·
net new positions -7.7%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | +2 | 83.38M | $1.50B | +13 | −12 |
| Q1 2026 | 111 | +1 | 76.41M | $1.66B | +6 | −6 |
| Q4 2025 | 110 | +2 | 75.97M | $1.63B | +3 | — |
| Q3 2025 | 17 | 0 | 44.07M | $848.49M | +2 | −3 |
| Q2 2025 | 15 | -1 | 40.14M | $686.46M | +1 | −2 |
| Q1 2025 | 13 | -1 | 11.03M | $703.96M | +1 | −2 |
| Q4 2024 | 14 | -1 | 10.27M | $1.25B | +2 | −3 |
| Q3 2024 | 14 | +1 | 7.65M | $955.24M | +1 | — |
| Q2 2024 | 13 | — | 7.85M | $1.24B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 4.07M | 0.0% | $259.65M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.65M | +27.9% | $168.91M | 0.0% | ▲ Add | 4 | SEC ↗ ×8 |
| 3 | Geode Capital Management ✦ (passive) | 1.82M | +6.7% | $116.24M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 1.19M | +14.8% | $76.10M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 550.88K | +634.0% | $35.16M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 238.25K | -1.4% | $15.21M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 235.79K | -61.8% | $15.05M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 206.94K | +1491.6% | $13.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Marshall Wace ✦ | 27.20K | New | $1.74M | 0.0% | New | 1 | SEC ↗ ×2 |
| 10 | Bridgewater Associates ✦ | 19.82K | +277.9% | $1.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 12.76K | -28.7% | $814,342 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 5.38K | +214.2% | $343,671 | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 13 | D. E. Shaw & Co. ✦ | 4.41K | +25.9% | $281,191 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $1.74M | 0.0% |
Exited
| Soros Fund Management | $28.07M | was 0.7% |
| Adage Capital Partners | $21.28M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 339 holders, 102.41M shares, $2.16B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.